Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience)
Cirkel, U.; Schweppe, K.W.; Ochs, H.; Schneider, H.P.
Progress in Clinical and Biological Research 225: 189-199
1986
ISSN/ISBN: 0361-7742 PMID: 3097665 Document Number: 269328
Document emailed within 1 workday
Related Documents
Agarwal, S.K. 2002: Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density? Journal of Reproductive Medicine 47(7): 530-534Pŭnevska, M.; Filipov, E.; Nalbanski, A.; Nalbanski, B. 2004: Gonadotropin-releasing agonist in the therapy of patients with laparoscopically confirmed endometriosis Akusherstvo i Ginekologiia 43(Suppl 4): 58-60
Steingold, K.A.; Cedars, M.; Lu, J.K.; Randle, D.; Judd, H.L.; Meldrum, D.R. 1987: Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist Obstetrics and Gynecology 69(3 Part 1): 403-411
Long, Q.-q.; Zhang, S.-f.; Han, Y.; Chen, H.; Li, X.-l.; Hua, K.-q.; Hu, W.-g. 2010: Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis Zhonghua Fu Chan Ke Za Zhi 45(4): 247-251
Wang, J.-h.; Zhou, F.-z.; Dong, M.-y.; Yuan, L. 2005: Influences of gonadotropin releasing hormone agonist treatment on nitric oxide synthase expression in women with endometriosis and infertility Zhonghua Fu Chan Ke Za Zhi 40(6): 383-387
Manetta, L.A.; de Paula Martins, W.; Rosa e Silva, J.úl.C.és.; de Sá Rosa e Silva, A.C.J.; Nogueira, A.ôn.A.; Ferriani, R.A. 2008: Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist Ultrasound in Medicine and Biology 34(12): 1914-1918
Lemay, A.; Quesnel, G. 1982: Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist Fertility and Sterility 38(3): 376-379
Kratochvílovà, B.; Profant, O.; Astl, J.ír.; Holý, R. 2016: Our experience in the treatment of idiopathic sensorineural hearing loss (ISNHL): Effect of combination therapy with HBO₂ and vasodilator infusion therapy Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 43(7): 771-780
Arowojolu, A.O. 2000: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience African Journal of Medicine and Medical Sciences 29(1): 55-58
Cirkel, U.; Ochs, H.; Schneider, H.P.; Mettler, L.; Mayer-Eichberger, D.; Schindler, A.E.; Bühler, K.; Winkler, U.; Zahradnik, H.P.; Künzig, H.J. 1992: Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study Clinical Therapeutics 14 Suppl A: 37-50
Rotkina, I.E. 1978: Cause-effect relationships between endometriosis and sterility and the prognosis for restoration of the child-bearing function depending on the type of therapy Akusherstvo i Ginekologiia 8: 56-59
Nisolle, M.; Clerckx, F.; Casanas-Roux, F.; Gillerot, S.; Bourgonjon, D.; Donnez, J. 1990: Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant) Journal de Gynecologie Obstetrique et Biologie de la Reproduction 19(6): 759-763
Regidor, P.A.; Imberg, C.; Bühler, K.; Reiners, C.; Schindler, A.E. 1993: Treatment of endometriosis with the GnRH analog triptorelin with special reference to the effect on bone density Zentralblatt für Gynakologie 115(11): 473-477
Dahlberg, B. 1987: A male factor in endometriosis. Correlation between endometriosis and asymptomatic bacteriospermia in male partners: a noninvasive infertility treatment Contributions to Gynecology and Obstetrics 16: 36-39
González González, C.F.; González Gutiérrez, J.T.; Gómez Ruiz Velasco, A. 1984: Endometriosis and sterility. Difference between disease endometriosis and implantation endometriosis Ginecologia y Obstetricia de Mexico 52(326): 153-155
Lôo, H.; Daléry, J.; Macher, J.P.; Payen, A. 2003: Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders L'Encephale 29(2): 165-171
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Khirmanov, V.N. 2003: Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use Terapevticheskii Arkhiv 75(2): 85-88
Malmberg; Mikaels; Mohell, N. 1998: Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding Journal of Pharmacology and Experimental Therapeutics 285(1): 119-126
Buck, K.J.; Harris, R.A. 1990: Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol Journal of Pharmacology and Experimental Therapeutics 253(2): 713-719